Login / Signup

Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.

Tim NestlerPia PaffenholzDavid PfisterJustine SchochAlessandro NiniAndreas HiesterPeter AlbersAxel Heidenreich
Published in: The Journal of urology (2023)
This study shows that 33% to 40% of all resections of adjacent organs do not harbor teratoma or viable GCT. This highlights the need for better patient selection for these complex patients.
Keyphrases